24-Mar-2011 - The UK has drafted a budget to attract and keep business but there are still significant barriers to investment, warns the CIA.
23-Mar-2011 - Switzerland-based Lonza has signed two new manufacturing deals with pharmaceutical firms that look set to improve capacity utilisation.
23-Mar-2011 - GSK is participating in a UK Government-backed innovative manufacturing initiative aimed at revitalising the sector.
23-Mar-2011 - Gerresheimer has bought Brazilian pharmaceutical plastic packaging maker Vedat, citing rapid growth of the country’s drug market, particularly the generics segment, as the main driver for the acquisition.
10-Mar-2011 - API maker IPCA laboratories has received UK MHRA approval for its formulations and production unit in Indore, India.
08-Mar-2011 - Swiss pharmaceutical ingredient maker Helsinn says its new cytotoxic API production plant will be operational for laboratory-scale projects early next year.
08-Mar-2011 - Thermo Fisher Scientific has launched a predictive assay that, it claims, can assess a drug candidate’s potential to cause liver damage earlier than traditional methods.
07-Mar-2011 - Charles River Laboratories (CRL) said it will distribute several Pfizer-developed R&D models, in a deal that continues the US CRO’s efforts to expand its lab animals business.
02-Mar-2011 - Lonza is working with energy broker Usource to reduce costs at a number of its US production and R&D facilities.
02-Mar-2011 - Clondalkin is to buy the printed components unit from Catalent as part of an ongoing acquisition strategy in the strong sector growth.
24-Feb-2011 - CMO Carbogen Amcis will restructure its Swiss manufacturing operations and cut jobs to combat “inadequate profitability” in a new plan announced late yesterday.
24-Feb-2011 - Mass-market drug manufacturers can turn a fixed cost into a service-providing revenue generator by investing in an agile supply chain, says PwC.
22-Feb-2011 - A radical overhaul of pharmaceutical supply chains is needed to prepare them for the type of products currently in development, says PwC.
21-Feb-2011 - UK-based Endeavour Specialty Chemicals has launched a range of thioamide intermediates, citing growing evidence of their potential role in development of new cancer treatments.
21-Feb-2011 - Operating profit at West tumbled in the fourth quarter as restructuring charges and the lack of H1N1 affected results.
17-Feb-2011 - Sanofi Aventis’ CEO, Chris Veibacher, said the French drugmaker may look at providing some fill/finish capacity for Genzyme in the long term.
17-Feb-2011 - Pfizer’s Capsugel unit has bought an injection molding technology that, it believes, will expand its capsule filling business into new “high value segments.”
17-Feb-2011 - The European Parliament has approved the falsified medicines directive and described it as a “huge step” in efforts to protect patients.
16-Feb-2011 - Canada lost more than 3,600 pharmaceutical jobs in the second half of 2010 as domestic and export sales slowed.
10-Feb-2011 - in-PharmaTechnologist presents a replay of our live blog covering all the news, views and multimedia from Informex 2011.
09-Feb-2011 - Global API service provider, ScinoPharm, is to begin the commercial manufacture of vilazodone hydrochloride, the active pharmaceutical ingredient (API) in Clinical Data Inc.'s new antidepressant, Viibryd.
09-Feb-2011 - Novasep and instrAction have partnered to develop improved methods for the production of taxane-based active pharmaceutical ingredients (API) citing growing demand for cancer treatments as key driver.
09-Feb-2011 - A bill requiring biopharm manufacturers to give the FDA early notification of potential drug shortages has been introduced to the US Senate.
08-Feb-2011 - Eli Lilly will factor the performance of candidate drugs into employee bonuses in future under a scheme designed to stress the importance of R&D.
07-Feb-2011 - Biopharm manufacturers should hold a volume of buffer stock to ensure it can maintain supply during fluctuations in demand, says UK guidance.